<DOC>
	<DOCNO>NCT01889316</DOCNO>
	<brief_summary>This prospective clinical trial involve use FDA-cleared Fetal ECG trace labor AN24 ( Fetal Monitoring device market Monica Healthcare ) Novii ( new device also create Monica Healthcare ) use technology different monitor placement .</brief_summary>
	<brief_title>Performance Comparison New Fetal/Maternal Monitor With FDA-cleared Method</brief_title>
	<detailed_description>This study one arm , Both FDA - Approved AN24 ( Fetal Monitoring device market Monica Healthcare ) new device ( Novii , investigate clinical trial ) place patient 's abdomen . After delivery patient 's infant , data abstract second device . This data compare data first device accuracy .</detailed_description>
	<mesh_term>Fetal Hypoxia</mesh_term>
	<criteria>Term Laboring Patients Preterm Labor Fetal Anomaly Imminent cesarean</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Fetal monitoring</keyword>
	<keyword>ECG</keyword>
</DOC>